Financial Year |
March 31 2023 |
Monetary Funds |
10,046,384,015.48 |
Held-for-trading Financial Assets |
114,020,833.68 |
Notes Receivable |
-- |
Accounts Receivable |
422,338,014.71 |
Advances to Suppliers |
25,766,134.13 |
Other Receivables |
30,533,471.89 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
1,255,395.25 |
Dividend Receivable |
-- |
Inventories |
699,639,229.09 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
2,740,032,290.41 |
Other Current Assets |
14,395,903.85 |
Total Current Assets |
14,093,332,257.44 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
126,658,936.58 |
Investment Properties |
250,276,549.64 |
Fixed Assetes |
1,987,748,280.92 |
Under-construction Projects |
208,053,479.16 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
541,133,701.87 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
39,926,990.49 |
Deferred Income Tax Assets |
101,860,510.64 |
Other Non-Current Assets |
4,391,055,238.36 |
Sub-Total of Non-Current Assets |
7,737,076,186.20 |
Total Assets |
21,830,408,443.64 |
Short-Term Loans |
511,250,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
5,738,682,444.24 |
Accounts Payable |
4,495,526,298.74 |
Accounts Received In Advance |
10,362,351.92 |
Employee Compensation Payable |
112,164,815.54 |
Taxes Payable |
222,286,357.80 |
Interest Payable |
500,000.00 |
Dividend Payable |
-- |
Other payables |
618,411,729.71 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
5,418,116.53 |
Other Current Liabilities |
15,485,248.85 |
Sub-Total of Current Liabilities |
12,338,725,095.57 |
Long-term Loans |
-- |
Bonds Payable |
1,569,497,243.85 |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
7,167,704.43 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,825,228,680.32 |
Total Liabilities |
14,163,953,775.89 |
Paid-In Capital(Or Share Stock) |
574,700,004.00 |
Capital Surplus |
1,990,702,535.20 |
Surplus Reserve |
290,784,296.91 |
LESS:Treasury Stock |
134,953,200.00 |
Undistributed Profits |
4,490,633,298.41 |
Minority Stockholder's Interest |
21,933,710.58 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,644,520,957.17 |
Owner's Equity(Stockholder's Equity) |
7,666,454,667.75 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
21,830,408,443.64 |